Pfizer Inc. [NYSE: PFE] gained 0.05% or 0.02 points to close at $42.81 with a heavy trading volume of 24549823 shares. The company report on July 28, 2021 that PFIZER REPORTS SECOND-QUARTER 2021 RESULTS.
Second-Quarter 2021 Revenues of $19.0 Billion, Reflecting 86% Operational Growth; Excluding BNT162b2(1), Revenues Grew 10% Operationally to $11.1 Billion.
The 10% Operational Growth Excluding BNT162b2(1) in Second-Quarter 2021 Builds on the 6% Operational Growth Delivered by the Comparable Business in Second-Quarter 2020.
It opened the trading session at $42.88, the shares rose to $43.185 and dropped to $42.69, the range by which the price of stock traded the whole day. The daily chart for PFE points out that the company has recorded 19.25% gains over the past six months. However, it is still -30.56% lower than its most recent low trading price.
If we look at the average trading volume of 25.87M shares, PFE reached to a volume of 24549823 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Pfizer Inc. [PFE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $42.97 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Pfizer Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 27, 2021. The new note on the price target was released on May 06, 2021, representing the official price target for Pfizer Inc. stock. Previously, the target price had yet another raise to $42, while RBC Capital Mkts analysts kept a Sector Perform rating on PFE stock.
The Average True Range (ATR) for Pfizer Inc. is set at 0.64, with the Price to Sales ratio for PFE stock in the period of the last 12 months amounting to 4.31. The Price to Book ratio for the last quarter was 3.48, with the Price to Cash per share for the same quarter was set at 2.44. Price to Free Cash Flow for PFE in the course of the last twelve months was 64.54 with Quick ratio for the last quarter at 1.20.
Trading performance analysis for PFE stock
Pfizer Inc. [PFE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.71. With this latest performance, PFE shares gained by 9.32% in over the last four-week period, additionally plugging by 19.25% over the last 6 months – not to mention a rise of 16.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PFE stock in for the last two-week period is set at 71.98, with the RSI for the last a single of trading hit 74.28, and the three-weeks RSI is set at 69.01 for Pfizer Inc. [PFE]. The present Moving Average for the last 50 days of trading for this stock 39.90, while it was recorded at 42.59 for the last single week of trading, and 37.76 for the last 200 days.
Pfizer Inc. [PFE]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Pfizer Inc. [PFE] shares currently have an operating margin of +21.52 and a Gross Margin at +71.21. Pfizer Inc.’s Net Margin is presently recorded at +16.67.
Return on Total Capital for PFE is now 8.14, given the latest momentum, and Return on Invested Capital for the company is 6.93. Return on Equity for this stock inclined to 11.05, with Return on Assets sitting at 4.34. When it comes to the capital structure of this company, Pfizer Inc. [PFE] has a Total Debt to Total Equity ratio set at 65.26. Additionally, PFE Total Debt to Total Capital is recorded at 39.49, with Total Debt to Total Assets ending up at 26.76. Long-Term Debt to Equity for the company is recorded at 60.48, with the Long-Term Debt to Total Capital now at 36.60.
Reflecting on the efficiency of the workforce at the company, Pfizer Inc. [PFE] managed to generate an average of $88,981 per employee. Receivables Turnover for the company is 5.03 with a Total Asset Turnover recorded at a value of 0.26.Pfizer Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.20 and a Current Ratio set at 1.50.
Pfizer Inc. [PFE]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PFE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pfizer Inc. go to 11.70%.
An analysis of insider ownership at Pfizer Inc. [PFE]
There are presently around $157,117 million, or 66.70% of PFE stock, in the hands of institutional investors. The top three institutional holders of PFE stocks are: VANGUARD GROUP INC with ownership of 450,914,119, which is approximately 0.66% of the company’s market cap and around 0.04% of the total institutional ownership; BLACKROCK INC., holding 405,733,970 shares of the stock with an approximate value of $17.37 billion in PFE stocks shares; and STATE STREET CORP, currently with $11.77 billion in PFE stock with ownership of nearly -1.679% of the company’s market capitalization.
Positions in Pfizer Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 1,401 institutional holders increased their position in Pfizer Inc. [NYSE:PFE] by around 146,020,043 shares. Additionally, 1,159 investors decreased positions by around 168,581,318 shares, while 238 investors held positions by with 3,355,509,538 shares. The mentioned changes placed institutional holdings at 3,670,110,899 shares, according to the latest SEC report filing. PFE stock had 158 new institutional investments in for a total of 20,683,414 shares, while 107 institutional investors sold positions of 11,540,811 shares during the same period.